img

Global Human Pain Management Drug Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Human Pain Management Drug Market Research Report 2024

Pain relievers, including acetaminophen, NSAIDs and opioids, can ease temporary aches and chronic pain.
According to Mr Accuracy reports’s new survey, global Human Pain Management Drug market is projected to reach US$ 96030 million in 2029, increasing from US$ 72000 million in 2022, with the CAGR of 4.2% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Human Pain Management Drug market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Human Pain Management Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


AbbVie Inc. (Allergan plc)
Bristol Myers Squibb Co.
Sanofi S.A.
Boehringer Ingelheim International GmbH
Pfizer Inc.
Zydus Lifesciences Ltd. (Cadila Pharmaceuticals)
GSK plc.
Abbott Laboratories, Inc.
Novartis AG
Johnson & Johnson (Janssen Pharmaceuticals, Inc.)
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceuticals Ltd.
Mallinckrodt Pharmaceuticals
Endo Pharmaceuticals Inc.
Bayer AG
F. Hoffmann-La Roche Ltd.
Procter & Gamble
AstraZeneca
Cardinal Health
Perrigo Company Plc.
Bausch Health Companies Inc.
Viatris
Amneal Pharmaceuticals
Purdue Pharmaceuticals L.P.
Segment by Type
OTC
Rx

Segment by Application


Hospital
Retail Pharmacy
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Human Pain Management Drug report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Pain Management Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 OTC
1.2.3 Rx
1.3 Market by Application
1.3.1 Global Human Pain Management Drug Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Pain Management Drug Market Perspective (2018-2029)
2.2 Human Pain Management Drug Growth Trends by Region
2.2.1 Global Human Pain Management Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Human Pain Management Drug Historic Market Size by Region (2018-2024)
2.2.3 Human Pain Management Drug Forecasted Market Size by Region (2024-2029)
2.3 Human Pain Management Drug Market Dynamics
2.3.1 Human Pain Management Drug Industry Trends
2.3.2 Human Pain Management Drug Market Drivers
2.3.3 Human Pain Management Drug Market Challenges
2.3.4 Human Pain Management Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Pain Management Drug Players by Revenue
3.1.1 Global Top Human Pain Management Drug Players by Revenue (2018-2024)
3.1.2 Global Human Pain Management Drug Revenue Market Share by Players (2018-2024)
3.2 Global Human Pain Management Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Human Pain Management Drug Revenue
3.4 Global Human Pain Management Drug Market Concentration Ratio
3.4.1 Global Human Pain Management Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Pain Management Drug Revenue in 2022
3.5 Human Pain Management Drug Key Players Head office and Area Served
3.6 Key Players Human Pain Management Drug Product Solution and Service
3.7 Date of Enter into Human Pain Management Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Pain Management Drug Breakdown Data by Type
4.1 Global Human Pain Management Drug Historic Market Size by Type (2018-2024)
4.2 Global Human Pain Management Drug Forecasted Market Size by Type (2024-2029)
5 Human Pain Management Drug Breakdown Data by Application
5.1 Global Human Pain Management Drug Historic Market Size by Application (2018-2024)
5.2 Global Human Pain Management Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Human Pain Management Drug Market Size (2018-2029)
6.2 North America Human Pain Management Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Human Pain Management Drug Market Size by Country (2018-2024)
6.4 North America Human Pain Management Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Human Pain Management Drug Market Size (2018-2029)
7.2 Europe Human Pain Management Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Human Pain Management Drug Market Size by Country (2018-2024)
7.4 Europe Human Pain Management Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Human Pain Management Drug Market Size (2018-2029)
8.2 Asia-Pacific Human Pain Management Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Human Pain Management Drug Market Size by Region (2018-2024)
8.4 Asia-Pacific Human Pain Management Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Human Pain Management Drug Market Size (2018-2029)
9.2 Latin America Human Pain Management Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Human Pain Management Drug Market Size by Country (2018-2024)
9.4 Latin America Human Pain Management Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Pain Management Drug Market Size (2018-2029)
10.2 Middle East & Africa Human Pain Management Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Human Pain Management Drug Market Size by Country (2018-2024)
10.4 Middle East & Africa Human Pain Management Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie Inc. (Allergan plc)
11.1.1 AbbVie Inc. (Allergan plc) Company Detail
11.1.2 AbbVie Inc. (Allergan plc) Business Overview
11.1.3 AbbVie Inc. (Allergan plc) Human Pain Management Drug Introduction
11.1.4 AbbVie Inc. (Allergan plc) Revenue in Human Pain Management Drug Business (2018-2024)
11.1.5 AbbVie Inc. (Allergan plc) Recent Development
11.2 Bristol Myers Squibb Co.
11.2.1 Bristol Myers Squibb Co. Company Detail
11.2.2 Bristol Myers Squibb Co. Business Overview
11.2.3 Bristol Myers Squibb Co. Human Pain Management Drug Introduction
11.2.4 Bristol Myers Squibb Co. Revenue in Human Pain Management Drug Business (2018-2024)
11.2.5 Bristol Myers Squibb Co. Recent Development
11.3 Sanofi S.A.
11.3.1 Sanofi S.A. Company Detail
11.3.2 Sanofi S.A. Business Overview
11.3.3 Sanofi S.A. Human Pain Management Drug Introduction
11.3.4 Sanofi S.A. Revenue in Human Pain Management Drug Business (2018-2024)
11.3.5 Sanofi S.A. Recent Development
11.4 Boehringer Ingelheim International GmbH
11.4.1 Boehringer Ingelheim International GmbH Company Detail
11.4.2 Boehringer Ingelheim International GmbH Business Overview
11.4.3 Boehringer Ingelheim International GmbH Human Pain Management Drug Introduction
11.4.4 Boehringer Ingelheim International GmbH Revenue in Human Pain Management Drug Business (2018-2024)
11.4.5 Boehringer Ingelheim International GmbH Recent Development
11.5 Pfizer Inc.
11.5.1 Pfizer Inc. Company Detail
11.5.2 Pfizer Inc. Business Overview
11.5.3 Pfizer Inc. Human Pain Management Drug Introduction
11.5.4 Pfizer Inc. Revenue in Human Pain Management Drug Business (2018-2024)
11.5.5 Pfizer Inc. Recent Development
11.6 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals)
11.6.1 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Company Detail
11.6.2 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Business Overview
11.6.3 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Human Pain Management Drug Introduction
11.6.4 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Revenue in Human Pain Management Drug Business (2018-2024)
11.6.5 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Recent Development
11.7 GSK plc.
11.7.1 GSK plc. Company Detail
11.7.2 GSK plc. Business Overview
11.7.3 GSK plc. Human Pain Management Drug Introduction
11.7.4 GSK plc. Revenue in Human Pain Management Drug Business (2018-2024)
11.7.5 GSK plc. Recent Development
11.8 Abbott Laboratories, Inc.
11.8.1 Abbott Laboratories, Inc. Company Detail
11.8.2 Abbott Laboratories, Inc. Business Overview
11.8.3 Abbott Laboratories, Inc. Human Pain Management Drug Introduction
11.8.4 Abbott Laboratories, Inc. Revenue in Human Pain Management Drug Business (2018-2024)
11.8.5 Abbott Laboratories, Inc. Recent Development
11.9 Novartis AG
11.9.1 Novartis AG Company Detail
11.9.2 Novartis AG Business Overview
11.9.3 Novartis AG Human Pain Management Drug Introduction
11.9.4 Novartis AG Revenue in Human Pain Management Drug Business (2018-2024)
11.9.5 Novartis AG Recent Development
11.10 Johnson & Johnson (Janssen Pharmaceuticals, Inc.)
11.10.1 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Company Detail
11.10.2 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Business Overview
11.10.3 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Human Pain Management Drug Introduction
11.10.4 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Revenue in Human Pain Management Drug Business (2018-2024)
11.10.5 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Recent Development
11.11 Sun Pharmaceutical Industries Ltd.
11.11.1 Sun Pharmaceutical Industries Ltd. Company Detail
11.11.2 Sun Pharmaceutical Industries Ltd. Business Overview
11.11.3 Sun Pharmaceutical Industries Ltd. Human Pain Management Drug Introduction
11.11.4 Sun Pharmaceutical Industries Ltd. Revenue in Human Pain Management Drug Business (2018-2024)
11.11.5 Sun Pharmaceutical Industries Ltd. Recent Development
11.12 Teva Pharmaceuticals Ltd.
11.12.1 Teva Pharmaceuticals Ltd. Company Detail
11.12.2 Teva Pharmaceuticals Ltd. Business Overview
11.12.3 Teva Pharmaceuticals Ltd. Human Pain Management Drug Introduction
11.12.4 Teva Pharmaceuticals Ltd. Revenue in Human Pain Management Drug Business (2018-2024)
11.12.5 Teva Pharmaceuticals Ltd. Recent Development
11.13 Mallinckrodt Pharmaceuticals
11.13.1 Mallinckrodt Pharmaceuticals Company Detail
11.13.2 Mallinckrodt Pharmaceuticals Business Overview
11.13.3 Mallinckrodt Pharmaceuticals Human Pain Management Drug Introduction
11.13.4 Mallinckrodt Pharmaceuticals Revenue in Human Pain Management Drug Business (2018-2024)
11.13.5 Mallinckrodt Pharmaceuticals Recent Development
11.14 Endo Pharmaceuticals Inc.
11.14.1 Endo Pharmaceuticals Inc. Company Detail
11.14.2 Endo Pharmaceuticals Inc. Business Overview
11.14.3 Endo Pharmaceuticals Inc. Human Pain Management Drug Introduction
11.14.4 Endo Pharmaceuticals Inc. Revenue in Human Pain Management Drug Business (2018-2024)
11.14.5 Endo Pharmaceuticals Inc. Recent Development
11.15 Bayer AG
11.15.1 Bayer AG Company Detail
11.15.2 Bayer AG Business Overview
11.15.3 Bayer AG Human Pain Management Drug Introduction
11.15.4 Bayer AG Revenue in Human Pain Management Drug Business (2018-2024)
11.15.5 Bayer AG Recent Development
11.16 F. Hoffmann-La Roche Ltd.
11.16.1 F. Hoffmann-La Roche Ltd. Company Detail
11.16.2 F. Hoffmann-La Roche Ltd. Business Overview
11.16.3 F. Hoffmann-La Roche Ltd. Human Pain Management Drug Introduction
11.16.4 F. Hoffmann-La Roche Ltd. Revenue in Human Pain Management Drug Business (2018-2024)
11.16.5 F. Hoffmann-La Roche Ltd. Recent Development
11.17 Procter & Gamble
11.17.1 Procter & Gamble Company Detail
11.17.2 Procter & Gamble Business Overview
11.17.3 Procter & Gamble Human Pain Management Drug Introduction
11.17.4 Procter & Gamble Revenue in Human Pain Management Drug Business (2018-2024)
11.17.5 Procter & Gamble Recent Development
11.18 AstraZeneca
11.18.1 AstraZeneca Company Detail
11.18.2 AstraZeneca Business Overview
11.18.3 AstraZeneca Human Pain Management Drug Introduction
11.18.4 AstraZeneca Revenue in Human Pain Management Drug Business (2018-2024)
11.18.5 AstraZeneca Recent Development
11.19 Cardinal Health
11.19.1 Cardinal Health Company Detail
11.19.2 Cardinal Health Business Overview
11.19.3 Cardinal Health Human Pain Management Drug Introduction
11.19.4 Cardinal Health Revenue in Human Pain Management Drug Business (2018-2024)
11.19.5 Cardinal Health Recent Development
11.20 Perrigo Company Plc.
11.20.1 Perrigo Company Plc. Company Detail
11.20.2 Perrigo Company Plc. Business Overview
11.20.3 Perrigo Company Plc. Human Pain Management Drug Introduction
11.20.4 Perrigo Company Plc. Revenue in Human Pain Management Drug Business (2018-2024)
11.20.5 Perrigo Company Plc. Recent Development
11.21 Bausch Health Companies Inc.
11.21.1 Bausch Health Companies Inc. Company Detail
11.21.2 Bausch Health Companies Inc. Business Overview
11.21.3 Bausch Health Companies Inc. Human Pain Management Drug Introduction
11.21.4 Bausch Health Companies Inc. Revenue in Human Pain Management Drug Business (2018-2024)
11.21.5 Bausch Health Companies Inc. Recent Development
11.22 Viatris
11.22.1 Viatris Company Detail
11.22.2 Viatris Business Overview
11.22.3 Viatris Human Pain Management Drug Introduction
11.22.4 Viatris Revenue in Human Pain Management Drug Business (2018-2024)
11.22.5 Viatris Recent Development
11.23 Amneal Pharmaceuticals
11.23.1 Amneal Pharmaceuticals Company Detail
11.23.2 Amneal Pharmaceuticals Business Overview
11.23.3 Amneal Pharmaceuticals Human Pain Management Drug Introduction
11.23.4 Amneal Pharmaceuticals Revenue in Human Pain Management Drug Business (2018-2024)
11.23.5 Amneal Pharmaceuticals Recent Development
11.24 Purdue Pharmaceuticals L.P.
11.24.1 Purdue Pharmaceuticals L.P. Company Detail
11.24.2 Purdue Pharmaceuticals L.P. Business Overview
11.24.3 Purdue Pharmaceuticals L.P. Human Pain Management Drug Introduction
11.24.4 Purdue Pharmaceuticals L.P. Revenue in Human Pain Management Drug Business (2018-2024)
11.24.5 Purdue Pharmaceuticals L.P. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Human Pain Management Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of OTC
Table 3. Key Players of Rx
Table 4. Global Human Pain Management Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Human Pain Management Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Human Pain Management Drug Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Human Pain Management Drug Market Share by Region (2018-2024)
Table 8. Global Human Pain Management Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Human Pain Management Drug Market Share by Region (2024-2029)
Table 10. Human Pain Management Drug Market Trends
Table 11. Human Pain Management Drug Market Drivers
Table 12. Human Pain Management Drug Market Challenges
Table 13. Human Pain Management Drug Market Restraints
Table 14. Global Human Pain Management Drug Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Human Pain Management Drug Market Share by Players (2018-2024)
Table 16. Global Top Human Pain Management Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Pain Management Drug as of 2022)
Table 17. Ranking of Global Top Human Pain Management Drug Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Human Pain Management Drug Revenue (CR5 and HHI) & (2018-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Human Pain Management Drug Product Solution and Service
Table 21. Date of Enter into Human Pain Management Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Human Pain Management Drug Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Human Pain Management Drug Revenue Market Share by Type (2018-2024)
Table 25. Global Human Pain Management Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Human Pain Management Drug Revenue Market Share by Type (2024-2029)
Table 27. Global Human Pain Management Drug Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Human Pain Management Drug Revenue Market Share by Application (2018-2024)
Table 29. Global Human Pain Management Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Human Pain Management Drug Revenue Market Share by Application (2024-2029)
Table 31. North America Human Pain Management Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Human Pain Management Drug Market Size by Country (2018-2024) & (US$ Million)
Table 33. North America Human Pain Management Drug Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Human Pain Management Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Human Pain Management Drug Market Size by Country (2018-2024) & (US$ Million)
Table 36. Europe Human Pain Management Drug Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Human Pain Management Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Human Pain Management Drug Market Size by Region (2018-2024) & (US$ Million)
Table 39. Asia-Pacific Human Pain Management Drug Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Human Pain Management Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Human Pain Management Drug Market Size by Country (2018-2024) & (US$ Million)
Table 42. Latin America Human Pain Management Drug Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Human Pain Management Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Human Pain Management Drug Market Size by Country (2018-2024) & (US$ Million)
Table 45. Middle East & Africa Human Pain Management Drug Market Size by Country (2024-2029) & (US$ Million)
Table 46. AbbVie Inc. (Allergan plc) Company Detail
Table 47. AbbVie Inc. (Allergan plc) Business Overview
Table 48. AbbVie Inc. (Allergan plc) Human Pain Management Drug Product
Table 49. AbbVie Inc. (Allergan plc) Revenue in Human Pain Management Drug Business (2018-2024) & (US$ Million)
Table 50. AbbVie Inc. (Allergan plc) Recent Development
Table 51. Bristol Myers Squibb Co. Company Detail
Table 52. Bristol Myers Squibb Co. Business Overview
Table 53. Bristol Myers Squibb Co. Human Pain Management Drug Product
Table 54. Bristol Myers Squibb Co. Revenue in Human Pain Management Drug Business (2018-2024) & (US$ Million)
Table 55. Bristol Myers Squibb Co. Recent Development
Table 56. Sanofi S.A. Company Detail
Table 57. Sanofi S.A. Business Overview
Table 58. Sanofi S.A. Human Pain Management Drug Product
Table 59. Sanofi S.A. Revenue in Human Pain Management Drug Business (2018-2024) & (US$ Million)
Table 60. Sanofi S.A. Recent Development
Table 61. Boehringer Ingelheim International GmbH Company Detail
Table 62. Boehringer Ingelheim International GmbH Business Overview
Table 63. Boehringer Ingelheim International GmbH Human Pain Management Drug Product
Table 64. Boehringer Ingelheim International GmbH Revenue in Human Pain Management Drug Business (2018-2024) & (US$ Million)
Table 65. Boehringer Ingelheim International GmbH Recent Development
Table 66. Pfizer Inc. Company Detail
Table 67. Pfizer Inc. Business Overview
Table 68. Pfizer Inc. Human Pain Management Drug Product
Table 69. Pfizer Inc. Revenue in Human Pain Management Drug Business (2018-2024) & (US$ Million)
Table 70. Pfizer Inc. Recent Development
Table 71. Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Company Detail
Table 72. Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Business Overview
Table 73. Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Human Pain Management Drug Product
Table 74. Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Revenue in Human Pain Management Drug Business (2018-2024) & (US$ Million)
Table 75. Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Recent Development
Table 76. GSK plc. Company Detail
Table 77. GSK plc. Business Overview
Table 78. GSK plc. Human Pain Management Drug Product
Table 79. GSK plc. Revenue in Human Pain Management Drug Business (2018-2024) & (US$ Million)
Table 80. GSK plc. Recent Development
Table 81. Abbott Laboratories, Inc. Company Detail
Table 82. Abbott Laboratories, Inc. Business Overview
Table 83. Abbott Laboratories, Inc. Human Pain Management Drug Product
Table 84. Abbott Laboratories, Inc. Revenue in Human Pain Management Drug Business (2018-2024) & (US$ Million)
Table 85. Abbott Laboratories, Inc. Recent Development
Table 86. Novartis AG Company Detail
Table 87. Novartis AG Business Overview
Table 88. Novartis AG Human Pain Management Drug Product
Table 89. Novartis AG Revenue in Human Pain Management Drug Business (2018-2024) & (US$ Million)
Table 90. Novartis AG Recent Development
Table 91. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Company Detail
Table 92. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Business Overview
Table 93. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Human Pain Management Drug Product
Table 94. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Revenue in Human Pain Management Drug Business (2018-2024) & (US$ Million)
Table 95. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Recent Development
Table 96. Sun Pharmaceutical Industries Ltd. Company Detail
Table 97. Sun Pharmaceutical Industries Ltd. Business Overview
Table 98. Sun Pharmaceutical Industries Ltd. Human Pain Management Drug Product
Table 99. Sun Pharmaceutical Industries Ltd. Revenue in Human Pain Management Drug Business (2018-2024) & (US$ Million)
Table 100. Sun Pharmaceutical Industries Ltd. Recent Development
Table 101. Teva Pharmaceuticals Ltd. Company Detail
Table 102. Teva Pharmaceuticals Ltd. Business Overview
Table 103. Teva Pharmaceuticals Ltd. Human Pain Management Drug Product
Table 104. Teva Pharmaceuticals Ltd. Revenue in Human Pain Management Drug Business (2018-2024) & (US$ Million)
Table 105. Teva Pharmaceuticals Ltd. Recent Development
Table 106. Mallinckrodt Pharmaceuticals Company Detail
Table 107. Mallinckrodt Pharmaceuticals Business Overview
Table 108. Mallinckrodt Pharmaceuticals Human Pain Management Drug Product
Table 109. Mallinckrodt Pharmaceuticals Revenue in Human Pain Management Drug Business (2018-2024) & (US$ Million)
Table 110. Mallinckrodt Pharmaceuticals Recent Development
Table 111. Endo Pharmaceuticals Inc. Company Detail
Table 112. Endo Pharmaceuticals Inc. Business Overview
Table 113. Endo Pharmaceuticals Inc. Human Pain Management Drug Product
Table 114. Endo Pharmaceuticals Inc. Revenue in Human Pain Management Drug Business (2018-2024) & (US$ Million)
Table 115. Endo Pharmaceuticals Inc. Recent Development
Table 116. Bayer AG Company Detail
Table 117. Bayer AG Business Overview
Table 118. Bayer AG Human Pain Management Drug Product
Table 119. Bayer AG Revenue in Human Pain Management Drug Business (2018-2024) & (US$ Million)
Table 120. Bayer AG Recent Development
Table 121. F. Hoffmann-La Roche Ltd. Company Detail
Table 122. F. Hoffmann-La Roche Ltd. Business Overview
Table 123. F. Hoffmann-La Roche Ltd. Human Pain Management Drug Product
Table 124. F. Hoffmann-La Roche Ltd. Revenue in Human Pain Management Drug Business (2018-2024) & (US$ Million)
Table 125. F. Hoffmann-La Roche Ltd. Recent Development
Table 126. Procter & Gamble Company Detail
Table 127. Procter & Gamble Business Overview
Table 128. Procter & Gamble Human Pain Management Drug Product
Table 129. Procter & Gamble Revenue in Human Pain Management Drug Business (2018-2024) & (US$ Million)
Table 130. Procter & Gamble Recent Development
Table 131. AstraZeneca Company Detail
Table 132. AstraZeneca Business Overview
Table 133. AstraZeneca Human Pain Management Drug Product
Table 134. AstraZeneca Revenue in Human Pain Management Drug Business (2018-2024) & (US$ Million)
Table 135. AstraZeneca Recent Development
Table 136. Cardinal Health Company Detail
Table 137. Cardinal Health Business Overview
Table 138. Cardinal Health Human Pain Management Drug Product
Table 139. Cardinal Health Revenue in Human Pain Management Drug Business (2018-2024) & (US$ Million)
Table 140. Cardinal Health Recent Development
Table 141. Perrigo Company Plc. Company Detail
Table 142. Perrigo Company Plc. Business Overview
Table 143. Perrigo Company Plc. Human Pain Management Drug Product
Table 144. Perrigo Company Plc. Revenue in Human Pain Management Drug Business (2018-2024) & (US$ Million)
Table 145. Perrigo Company Plc. Recent Development
Table 146. Bausch Health Companies Inc. Company Detail
Table 147. Bausch Health Companies Inc. Business Overview
Table 148. Bausch Health Companies Inc. Human Pain Management Drug Product
Table 149. Bausch Health Companies Inc. Revenue in Human Pain Management Drug Business (2018-2024) & (US$ Million)
Table 150. Bausch Health Companies Inc. Recent Development
Table 151. Viatris Company Detail
Table 152. Viatris Business Overview
Table 153. Viatris Human Pain Management Drug Product
Table 154. Viatris Revenue in Human Pain Management Drug Business (2018-2024) & (US$ Million)
Table 155. Viatris Recent Development
Table 156. Amneal Pharmaceuticals Company Detail
Table 157. Amneal Pharmaceuticals Business Overview
Table 158. Amneal Pharmaceuticals Human Pain Management Drug Product
Table 159. Amneal Pharmaceuticals Revenue in Human Pain Management Drug Business (2018-2024) & (US$ Million)
Table 160. Amneal Pharmaceuticals Recent Development
Table 161. Purdue Pharmaceuticals L.P. Company Detail
Table 162. Purdue Pharmaceuticals L.P. Business Overview
Table 163. Purdue Pharmaceuticals L.P. Human Pain Management Drug Product
Table 164. Purdue Pharmaceuticals L.P. Revenue in Human Pain Management Drug Business (2018-2024) & (US$ Million)
Table 165. Purdue Pharmaceuticals L.P. Recent Development
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Human Pain Management Drug Market Size Comparison by Type (2024-2029) & (US$ Million)
Figure 2. Global Human Pain Management Drug Market Share by Type: 2022 VS 2029
Figure 3. OTC Features
Figure 4. Rx Features
Figure 5. Global Human Pain Management Drug Market Size Comparison by Application (2024-2029) & (US$ Million)
Figure 6. Global Human Pain Management Drug Market Share by Application: 2022 VS 2029
Figure 7. Hospital Case Studies
Figure 8. Retail Pharmacy Case Studies
Figure 9. Other Case Studies
Figure 10. Human Pain Management Drug Report Years Considered
Figure 11. Global Human Pain Management Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Human Pain Management Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Human Pain Management Drug Market Share by Region: 2022 VS 2029
Figure 14. Global Human Pain Management Drug Market Share by Players in 2022
Figure 15. Global Top Human Pain Management Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Pain Management Drug as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Human Pain Management Drug Revenue in 2022
Figure 17. North America Human Pain Management Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Human Pain Management Drug Market Share by Country (2018-2029)
Figure 19. United States Human Pain Management Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Human Pain Management Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Human Pain Management Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Human Pain Management Drug Market Share by Country (2018-2029)
Figure 23. Germany Human Pain Management Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Human Pain Management Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Human Pain Management Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Human Pain Management Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Human Pain Management Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Human Pain Management Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Human Pain Management Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Human Pain Management Drug Market Share by Region (2018-2029)
Figure 31. China Human Pain Management Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Human Pain Management Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Human Pain Management Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Human Pain Management Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Human Pain Management Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Human Pain Management Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Human Pain Management Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Human Pain Management Drug Market Share by Country (2018-2029)
Figure 39. Mexico Human Pain Management Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Human Pain Management Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Human Pain Management Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Human Pain Management Drug Market Share by Country (2018-2029)
Figure 43. Turkey Human Pain Management Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Human Pain Management Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. AbbVie Inc. (Allergan plc) Revenue Growth Rate in Human Pain Management Drug Business (2018-2024)
Figure 46. Bristol Myers Squibb Co. Revenue Growth Rate in Human Pain Management Drug Business (2018-2024)
Figure 47. Sanofi S.A. Revenue Growth Rate in Human Pain Management Drug Business (2018-2024)
Figure 48. Boehringer Ingelheim International GmbH Revenue Growth Rate in Human Pain Management Drug Business (2018-2024)
Figure 49. Pfizer Inc. Revenue Growth Rate in Human Pain Management Drug Business (2018-2024)
Figure 50. Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Revenue Growth Rate in Human Pain Management Drug Business (2018-2024)
Figure 51. GSK plc. Revenue Growth Rate in Human Pain Management Drug Business (2018-2024)
Figure 52. Abbott Laboratories, Inc. Revenue Growth Rate in Human Pain Management Drug Business (2018-2024)
Figure 53. Novartis AG Revenue Growth Rate in Human Pain Management Drug Business (2018-2024)
Figure 54. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Revenue Growth Rate in Human Pain Management Drug Business (2018-2024)
Figure 55. Sun Pharmaceutical Industries Ltd. Revenue Growth Rate in Human Pain Management Drug Business (2018-2024)
Figure 56. Teva Pharmaceuticals Ltd. Revenue Growth Rate in Human Pain Management Drug Business (2018-2024)
Figure 57. Mallinckrodt Pharmaceuticals Revenue Growth Rate in Human Pain Management Drug Business (2018-2024)
Figure 58. Endo Pharmaceuticals Inc. Revenue Growth Rate in Human Pain Management Drug Business (2018-2024)
Figure 59. Bayer AG Revenue Growth Rate in Human Pain Management Drug Business (2018-2024)
Figure 60. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Human Pain Management Drug Business (2018-2024)
Figure 61. Procter & Gamble Revenue Growth Rate in Human Pain Management Drug Business (2018-2024)
Figure 62. AstraZeneca Revenue Growth Rate in Human Pain Management Drug Business (2018-2024)
Figure 63. Cardinal Health Revenue Growth Rate in Human Pain Management Drug Business (2018-2024)
Figure 64. Perrigo Company Plc. Revenue Growth Rate in Human Pain Management Drug Business (2018-2024)
Figure 65. Bausch Health Companies Inc. Revenue Growth Rate in Human Pain Management Drug Business (2018-2024)
Figure 66. Viatris Revenue Growth Rate in Human Pain Management Drug Business (2018-2024)
Figure 67. Amneal Pharmaceuticals Revenue Growth Rate in Human Pain Management Drug Business (2018-2024)
Figure 68. Purdue Pharmaceuticals L.P. Revenue Growth Rate in Human Pain Management Drug Business (2018-2024)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries